- ICH GCP
- US Clinical Trials Registry
- Klinisk utprøving NCT00770809
Paclitaxel og Trastuzumab med eller uten lapatinib ved behandling av pasienter med stadium II eller stadium III brystkreft som kan fjernes ved kirurgi
Randomisert fase III-studie av Paclitaxel + Trastuzumab + Lapatinib versus Paclitaxel + Trastuzumab som neoadjuvant behandling av HER2-positiv primær brystkreft
Studieoversikt
Status
Forhold
Intervensjon / Behandling
Detaljert beskrivelse
HOVEDMÅL:
I. For å bestemme om den patologiske fullstendige responsen (pCR) i brystet på neoadjuvant ukentlig paklitaksel med trastuzumab pluss lapatinib (THL) er 20 % høyere enn pCR til ukentlig paklitaksel med trastuzumab alene (TH).
SEKUNDÆRE MÅL:
I. For å bestemme den patologiske fullstendige responsen i bryst og aksill, ved å bruke American Joint Committee on Cancer (AJCC) tumor-, lymfeknuter- og metastasekriterier (versjon 6), på neoadjuvant ukentlig paklitaksel pluss human epidermal vekstfaktor 2 (HER2) )- målrettet terapi hos pasienter med HER2-positiv operabel brystkreft.
II. For å evaluere gjenværende kreftbelastning (RCB) som en prediktor for langsiktig tilbakefallsfri overlevelse (RFS) og total overlevelse (OS).
III. For å dokumentere toksisiteten til alle kjemoterapeutiske regimer (THL, TH). IV. For å bestemme sammenhengen mellom klinisk, radiografisk og patologisk respons.
V. For å sammenligne total overlevelse (OS), tilbakefallsfri overlevelse (RFS) og tid til første svikt (TFF) blant behandlingsgruppene.
VI. For å skaffe blod, ferskt frosset og fiksert tumorvev for å teste spesifikke hypoteser som det finnes biomarkørdata for og for å evaluere biomarkører i blod, serum og vev som sannsynligvis vil påvirke respons på og toksisitet av trastuzumab alene eller trastuzumab pluss lapatinib, når det gis sammen med paklitaksel. .
VII. For å bestemme kirurgiske praksismønstre for brystkonservering og sentinel lymfadenektomi hos pasienter som gjennomgår neoadjuvant kjemoterapi.
VIII. For å bestemme stråleterapipraksismønstrene for postmastektomi og regional nodalbestråling hos pasienter som gjennomgår neoadjuvant kjemoterapi.
IX. For å evaluere farmakogenomiske determinanter for toksisitet.
OVERSIKT: Pasienter er randomisert til 1 av 3 behandlingsarmer.
ARM I: Pasienter får trastuzumab IV over 30-90 minutter og paklitaksel IV over 1 time én gang ukentlig og lapatinib ditosylat oralt (PO) én gang daglig i 16 uker i fravær av sykdomsprogresjon eller uakseptabel toksisitet.
ARM II: Pasienter får trastuzumab og paklitaksel som i arm I.
ARM III: Pasienter får paklitaksel og lapatinib ditosylat som i arm I. (avbrutt fra 6-15-11) Innen 42 dager etter fullført neoadjuvant terapi gjennomgår pasienter i begge armer definitiv kirurgi (brystkonservering eller total mastektomi).
Etter avsluttet studiebehandling følges pasientene hver 6. måned i 2 år og deretter årlig i opptil 10 år.
Studietype
Registrering (Faktiske)
Fase
- Fase 3
Kontakter og plasseringer
Studiesteder
-
-
Arizona
-
Tucson, Arizona, Forente stater, 85719
- Banner University Medical Center - Tucson
-
-
Arkansas
-
Fort Smith, Arkansas, Forente stater, 72901
- Sparks Regional Medical Center
-
-
California
-
Burbank, California, Forente stater, 91505
- Providence Saint Joseph Medical Center/Disney Family Cancer Center
-
Castro Valley, California, Forente stater, 94546
- Eden Hospital Medical Center
-
Castro Valley, California, Forente stater, 94546
- East Bay Radiation Oncology Center
-
Castro Valley, California, Forente stater, 94546
- Valley Medical Oncology Consultants-Castro Valley
-
Emeryville, California, Forente stater, 94608
- Bay Area Breast Surgeons Inc
-
Fremont, California, Forente stater, 94538
- Valley Medical Oncology Consultants-Fremont
-
Martinez, California, Forente stater, 94553-3156
- Contra Costa Regional Medical Center
-
Mountain View, California, Forente stater, 94040
- El Camino Hospital
-
Mountain View, California, Forente stater, 94040
- Palo Alto Medical Foundation-Camino Division
-
Oakland, California, Forente stater, 94609
- Alta Bates Summit Medical Center - Summit Campus
-
Oakland, California, Forente stater, 94609
- Hematology and Oncology Associates-Oakland
-
Oakland, California, Forente stater, 94609
- Tom K Lee Inc
-
Oakland, California, Forente stater, 94609
- Bay Area Tumor Institute
-
Oakland, California, Forente stater, 94602
- Wilma Chan Highland Hospital
-
Palm Springs, California, Forente stater, 92262
- Desert Regional Medical Center
-
Palo Alto, California, Forente stater, 94301
- Palo Alto Medical Foundation Health Care
-
Pleasanton, California, Forente stater, 94588
- Valley Care Health System - Pleasanton
-
Pleasanton, California, Forente stater, 94588
- Valley Medical Oncology Consultants
-
Sacramento, California, Forente stater, 95817
- University of California Davis Comprehensive Cancer Center
-
Salinas, California, Forente stater, 93901
- Salinas Valley Memorial
-
San Francisco, California, Forente stater, 94115
- UCSF Medical Center-Mount Zion
-
San Francisco, California, Forente stater, 94110
- Zuckerberg San Francisco General Hospital
-
San Pablo, California, Forente stater, 94806
- Doctors Medical Center- JC Robinson Regional Cancer Center
-
St. Helena, California, Forente stater, 94574
- Saint Helena Hospital
-
-
Colorado
-
Aurora, Colorado, Forente stater, 80012
- The Medical Center of Aurora
-
Boulder, Colorado, Forente stater, 80303
- Boulder Community Foothills Hospital
-
Colorado Springs, Colorado, Forente stater, 80907
- Penrose-Saint Francis Healthcare
-
Denver, Colorado, Forente stater, 80218
- Presbyterian - Saint Lukes Medical Center - Health One
-
Denver, Colorado, Forente stater, 80220
- Rose Medical Center
-
Denver, Colorado, Forente stater, 80222
- Western States Cancer Research NCORP
-
Denver, Colorado, Forente stater, 80218
- Saint Joseph Hospital - Cancer Centers of Colorado
-
Denver, Colorado, Forente stater, 80210
- AdventHealth Porter
-
Englewood, Colorado, Forente stater, 80113
- Swedish Medical Center
-
Grand Junction, Colorado, Forente stater, 81501
- Saint Mary's Hospital and Regional Medical Center
-
Greeley, Colorado, Forente stater, 80631
- Banner North Colorado Medical Center
-
Lakewood, Colorado, Forente stater, 80228
- Saint Anthony Hospital
-
Littleton, Colorado, Forente stater, 80122
- AdventHealth Littleton
-
Lone Tree, Colorado, Forente stater, 80124
- Sky Ridge Medical Center
-
Longmont, Colorado, Forente stater, 80501
- Longmont United Hospital
-
Loveland, Colorado, Forente stater, 80539
- Banner McKee Medical Center
-
Parker, Colorado, Forente stater, 80138
- AdventHealth Parker
-
Pueblo, Colorado, Forente stater, 81004
- Saint Mary Corwin Medical Center
-
Thornton, Colorado, Forente stater, 80229
- North Suburban Medical Center
-
Wheat Ridge, Colorado, Forente stater, 80401
- Intermountain Health Lutheran Hospital
-
-
Connecticut
-
Hartford, Connecticut, Forente stater, 06105
- Smilow Cancer Hospital Care Center at Saint Francis
-
Manchester, Connecticut, Forente stater, 06040
- Manchester Memorial Hospital
-
Middletown, Connecticut, Forente stater, 06457
- Middlesex Hospital
-
-
Delaware
-
Lewes, Delaware, Forente stater, 19958
- Beebe Medical Center
-
Newark, Delaware, Forente stater, 19718
- Christiana Care Health System-Christiana Hospital
-
-
District of Columbia
-
Washington D.C., District of Columbia, Forente stater, 20007
- MedStar Georgetown University Hospital
-
-
Florida
-
Daytona Beach, Florida, Forente stater, 32114
- Halifax Health Medical Center-Centers for Oncology
-
Fort Lauderdale, Florida, Forente stater, 33308
- Holy Cross Hospital
-
Gainesville, Florida, Forente stater, 32605
- Florida Cancer Specialists-Gainesville Cancer Center
-
Jupiter, Florida, Forente stater, 33458
- Jupiter Medical Center
-
Miami Beach, Florida, Forente stater, 33140
- Mount Sinai Medical Center
-
Weston, Florida, Forente stater, 33331
- Cleveland Clinic-Weston
-
-
Georgia
-
Atlanta, Georgia, Forente stater, 30342
- Emory Saint Joseph's Hospital
-
Atlanta, Georgia, Forente stater, 30309
- Piedmont Hospital
-
Atlanta, Georgia, Forente stater, 30342
- Northside Hospital
-
Atlanta, Georgia, Forente stater, 30342
- Atlanta Regional CCOP
-
Austell, Georgia, Forente stater, 30106
- WellStar Cobb Hospital
-
Columbus, Georgia, Forente stater, 31904
- John B Amos Cancer Center
-
Decatur, Georgia, Forente stater, 30033
- Emory Decatur Hospital
-
Fayetteville, Georgia, Forente stater, 30214
- Piedmont Fayette Hospital
-
Lawrenceville, Georgia, Forente stater, 30046
- Northside Hospital - Gwinnett
-
Macon, Georgia, Forente stater, 31201
- Atrium Health Navicent
-
Marietta, Georgia, Forente stater, 30060
- Wellstar Kennestone Hospital
-
Riverdale, Georgia, Forente stater, 30274
- Southern Regional Medical Center
-
Rome, Georgia, Forente stater, 30165
- Harbin Clinic Medical Oncology and Clinical Research
-
Savannah, Georgia, Forente stater, 31405
- Lewis Cancer and Research Pavilion at Saint Joseph's/Candler
-
-
Idaho
-
Boise, Idaho, Forente stater, 83706
- Saint Alphonsus Cancer Care Center-Boise
-
-
Illinois
-
Alton, Illinois, Forente stater, 62002
- OSF Saint Anthony's Health Center
-
Chicago, Illinois, Forente stater, 60637
- University of Chicago Comprehensive Cancer Center
-
Chicago, Illinois, Forente stater, 60612
- University of Illinois
-
Chicago, Illinois, Forente stater, 60608
- Mount Sinai Hospital Medical Center
-
Chicago, Illinois, Forente stater, 60631
- Presence Resurrection Medical Center
-
Chicago, Illinois, Forente stater, 60640
- Weiss Memorial Hospital
-
Downers Grove, Illinois, Forente stater, 60515
- Advocate Good Samaritan Hospital
-
Joliet, Illinois, Forente stater, 60435
- Duly Health and Care Joliet
-
Maywood, Illinois, Forente stater, 60153
- Loyola University Medical Center
-
Mount Vernon, Illinois, Forente stater, 62864
- SSM Health Good Samaritan
-
Oak Lawn, Illinois, Forente stater, 60453-2699
- Advocate Christ Medical Center
-
Rockford, Illinois, Forente stater, 61104
- Swedish American Hospital
-
-
Indiana
-
Beech Grove, Indiana, Forente stater, 46107
- Franciscan Saint Francis Health-Beech Grove
-
Fort Wayne, Indiana, Forente stater, 46845
- Fort Wayne Medical Oncology and Hematology Inc-Parkview
-
Richmond, Indiana, Forente stater, 47374
- Reid Health
-
-
Iowa
-
Ames, Iowa, Forente stater, 50010
- McFarland Clinic - Ames
-
Bettendorf, Iowa, Forente stater, 52722
- University of Iowa Healthcare Cancer Services Quad Cities
-
Clive, Iowa, Forente stater, 50325
- UI Health Care Mission Cancer and Blood - West Des Moines Clinic
-
Des Moines, Iowa, Forente stater, 50309
- Iowa Methodist Medical Center
-
Des Moines, Iowa, Forente stater, 50314
- Mercy Medical Center - Des Moines
-
Des Moines, Iowa, Forente stater, 50316
- Iowa Lutheran Hospital
-
Des Moines, Iowa, Forente stater, 50309
- Iowa-Wide Oncology Research Coalition NCORP
-
Des Moines, Iowa, Forente stater, 50307
- Mercy Capitol
-
Des Moines, Iowa, Forente stater, 50309
- UI Health Care Mission Cancer and Blood - Des Moines Clinic
-
Des Moines, Iowa, Forente stater, 50314
- UI Health Care Mission Cancer and Blood - Laurel Clinic
-
Iowa City, Iowa, Forente stater, 52242
- University of Iowa/Holden Comprehensive Cancer Center
-
Sioux City, Iowa, Forente stater, 51101
- Siouxland Regional Cancer Center
-
Sioux City, Iowa, Forente stater, 51102
- Mercy Medical Center-Sioux City
-
Sioux City, Iowa, Forente stater, 51104
- Saint Luke's Regional Medical Center
-
-
Kansas
-
Hays, Kansas, Forente stater, 67601
- HaysMed
-
Hutchinson, Kansas, Forente stater, 67502
- Hutchinson Regional Medical Center
-
Kansas City, Kansas, Forente stater, 66160
- University of Kansas Cancer Center
-
Pittsburg, Kansas, Forente stater, 66762
- Mercy Hospital Pittsburg
-
Salina, Kansas, Forente stater, 67401
- Salina Regional Health Center
-
Topeka, Kansas, Forente stater, 66606
- University of Kansas Health System Saint Francis Campus
-
Topeka, Kansas, Forente stater, 66606
- Cotton O'Neil Cancer Center / Stormont Vail Health
-
-
Maine
-
Augusta, Maine, Forente stater, 04330
- Harold Alfond Center for Cancer Care
-
Bangor, Maine, Forente stater, 04401
- Eastern Maine Medical Center
-
-
Maryland
-
Baltimore, Maryland, Forente stater, 21201
- University of Maryland/Greenebaum Cancer Center
-
Bethesda, Maryland, Forente stater, 20889-5600
- Walter Reed National Military Medical Center
-
Elkton, Maryland, Forente stater, 21921
- Christiana Care - Union Hospital
-
Salisbury, Maryland, Forente stater, 21801
- TidalHealth Peninsula Regional
-
Silver Spring, Maryland, Forente stater, 20910
- Holy Cross Hospital
-
-
Massachusetts
-
Attleboro, Massachusetts, Forente stater, 02703
- Sturdy Memorial Hospital
-
Boston, Massachusetts, Forente stater, 02215
- Beth Israel Deaconess Medical Center
-
Boston, Massachusetts, Forente stater, 02215
- Dana-Farber Cancer Institute
-
Boston, Massachusetts, Forente stater, 02115
- Brigham and Women's Hospital
-
Boston, Massachusetts, Forente stater, 02111
- Tufts Medical Center
-
Boston, Massachusetts, Forente stater, 02114
- Massachusetts General Hospital Cancer Center
-
Brighton, Massachusetts, Forente stater, 02135
- Dana-Farber Cancer Institute at Boston Medical Center - Brighton
-
Milford, Massachusetts, Forente stater, 01757
- Dana-Farber/Brigham and Women's Cancer Center at Milford Regional
-
Newton, Massachusetts, Forente stater, 02462
- Newton-Wellesley Hospital
-
-
Michigan
-
Ann Arbor, Michigan, Forente stater, 48109
- University of Michigan Comprehensive Cancer Center
-
Ann Arbor, Michigan, Forente stater, 48106
- Michigan Cancer Research Consortium NCORP
-
Ann Arbor, Michigan, Forente stater, 48106
- Trinity Health Saint Joseph Mercy Hospital Ann Arbor
-
Dearborn, Michigan, Forente stater, 48124
- Corewell Health Dearborn Hospital
-
Detroit, Michigan, Forente stater, 48236
- Henry Ford Health Saint John Hospital
-
Flint, Michigan, Forente stater, 48532
- Genesys Regional Medical Center-West Flint Campus
-
Flint, Michigan, Forente stater, 48503
- Hurley Medical Center
-
Grand Blanc, Michigan, Forente stater, 48439
- Genesys Regional Medical Center
-
Jackson, Michigan, Forente stater, 49201
- Allegiance Health
-
Kalamazoo, Michigan, Forente stater, 49007
- West Michigan Cancer Center
-
Kalamazoo, Michigan, Forente stater, 49007
- Bronson Methodist Hospital
-
Kalamazoo, Michigan, Forente stater, 49048
- Beacon Kalamazoo
-
Lansing, Michigan, Forente stater, 48912
- University of Michigan Health - Sparrow Lansing
-
Livonia, Michigan, Forente stater, 48154
- Trinity Health Saint Mary Mercy Livonia Hospital
-
Pontiac, Michigan, Forente stater, 48341
- Trinity Health Saint Joseph Mercy Oakland Hospital
-
Port Huron, Michigan, Forente stater, 48060
- Lake Huron Medical Center
-
Saginaw, Michigan, Forente stater, 48601
- MyMichigan Medical Center Saginaw
-
Southfield, Michigan, Forente stater, 48075
- Henry Ford Health Providence Southfield Hospital
-
Warren, Michigan, Forente stater, 48093
- Henry Ford Health Warren Hospital
-
-
Minnesota
-
Mankato, Minnesota, Forente stater, 56001
- Mayo Clinic Health Systems-Mankato
-
-
Missouri
-
Cape Girardeau, Missouri, Forente stater, 63703
- Saint Francis Medical Center
-
Cape Girardeau, Missouri, Forente stater, 63701
- Southeast Missouri Hospital
-
Cape Girardeau, Missouri, Forente stater, 63703
- Mercy Cancer Center - Cape Girardeau
-
Jefferson City, Missouri, Forente stater, 65109
- MU Health Care Goldschmidt Cancer Center
-
Kansas City, Missouri, Forente stater, 64108
- University Health Truman Medical Center
-
St Louis, Missouri, Forente stater, 63110
- Washington University School of Medicine
-
St Louis, Missouri, Forente stater, 63131
- Missouri Baptist Medical Center
-
St Louis, Missouri, Forente stater, 63109
- Mercy Infusion Center - Chippewa
-
St Louis, Missouri, Forente stater, 63141
- Comprehensive Cancer Care PC
-
St Louis, Missouri, Forente stater, 63141
- Mercy Hospital Saint Louis
-
St Louis, Missouri, Forente stater, 63141
- Saint Louis-Cape Girardeau CCOP
-
St Louis, Missouri, Forente stater, 63141
- Center for Cancer Care and Research
-
-
Montana
-
Billings, Montana, Forente stater, 59101
- Billings Clinic Cancer Center
-
Billings, Montana, Forente stater, 59101
- Saint Vincent Healthcare
-
Billings, Montana, Forente stater, 59102
- Montana Cancer Consortium NCORP
-
Billings, Montana, Forente stater, 59101
- Northern Rockies Radiation Oncology Center
-
Billings, Montana, Forente stater, 59102
- Saint Vincent Frontier Cancer Center
-
Bozeman, Montana, Forente stater, 59715
- Bozeman Health Deaconess Hospital
-
Butte, Montana, Forente stater, 59701
- Saint James Community Hospital and Cancer Treatment Center
-
Great Falls, Montana, Forente stater, 59405
- Great Falls Clinic
-
Great Falls, Montana, Forente stater, 59405
- Berdeaux, Donald MD (UIA Investigator)
-
Great Falls, Montana, Forente stater, 59405
- Benefis Sletten Cancer Institute
-
Havre, Montana, Forente stater, 59501
- Northern Montana Hospital
-
Helena, Montana, Forente stater, 59601
- Saint Peter's Community Hospital
-
Kalispell, Montana, Forente stater, 59901
- Glacier Oncology PLLC
-
Kalispell, Montana, Forente stater, 59901
- Kalispell Medical Oncology
-
Kalispell, Montana, Forente stater, 59901
- Logan Health Medical Center
-
Missoula, Montana, Forente stater, 59802
- Saint Patrick Hospital - Community Hospital
-
Missoula, Montana, Forente stater, 59804
- Guardian Oncology and Center for Wellness
-
Missoula, Montana, Forente stater, 59802
- Montana Cancer Specialists
-
Missoula, Montana, Forente stater, 59804
- Community Medical Center
-
-
Nebraska
-
Lincoln, Nebraska, Forente stater, 68510
- Nebraska Cancer Research Center
-
Omaha, Nebraska, Forente stater, 68124
- Alegent Health Bergan Mercy Medical Center
-
Omaha, Nebraska, Forente stater, 68122
- Alegent Health Immanuel Medical Center
-
Omaha, Nebraska, Forente stater, 68130
- Alegent Health Lakeside Hospital
-
Omaha, Nebraska, Forente stater, 68131
- Creighton University Medical Center
-
Omaha, Nebraska, Forente stater, 68106
- Missouri Valley Cancer Consortium
-
-
Nevada
-
Las Vegas, Nevada, Forente stater, 89102
- University Medical Center of Southern Nevada
-
Las Vegas, Nevada, Forente stater, 89120
- Nevada Cancer Research Foundation NCORP
-
Reno, Nevada, Forente stater, 89502
- Renown Regional Medical Center
-
-
New Hampshire
-
Concord, New Hampshire, Forente stater, 03301
- New Hampshire Oncology Hematology PA-Concord
-
Keene, New Hampshire, Forente stater, 03431
- Cheshire Medical Center-Dartmouth-Hitchcock Keene
-
Laconia, New Hampshire, Forente stater, 03246
- LRGHealthcare-Lakes Region General Hospital
-
Lebanon, New Hampshire, Forente stater, 03756
- Dartmouth Hitchcock Medical Center/Dartmouth Cancer Center
-
Manchester, New Hampshire, Forente stater, 03103
- Solinsky Center for Cancer Care
-
Manchester, New Hampshire, Forente stater, 03103
- Elliot Hospital
-
Manchester, New Hampshire, Forente stater, 03102
- Dartmouth Cancer Center - Manchester
-
Nashua, New Hampshire, Forente stater, 03060
- Foundation Medical Partners
-
-
New Jersey
-
Camden, New Jersey, Forente stater, 08103
- Cooper Hospital University Medical Center
-
Morristown, New Jersey, Forente stater, 07960
- Morristown Medical Center
-
Newark, New Jersey, Forente stater, 07101
- Rutgers New Jersey Medical School
-
Summit, New Jersey, Forente stater, 07902
- Overlook Hospital
-
-
New Mexico
-
Albuquerque, New Mexico, Forente stater, 87102
- Lovelace Medical Center-Saint Joseph Square
-
Albuquerque, New Mexico, Forente stater, 87106
- University of New Mexico Cancer Center
-
Albuquerque, New Mexico, Forente stater, 87106
- Hematology Oncology Associates
-
-
New York
-
Buffalo, New York, Forente stater, 14263
- Roswell Park Cancer Institute
-
East Syracuse, New York, Forente stater, 13057
- Hematology Oncology Associates of Central New York-East Syracuse
-
Elmhurst, New York, Forente stater, 11373
- Elmhurst Hospital Center
-
Jamaica, New York, Forente stater, 11432
- Queens Hospital Center
-
Lake Success, New York, Forente stater, 11042
- Northwell Health NCORP
-
Lake Success, New York, Forente stater, 11042
- Northwell Health/Center for Advanced Medicine
-
Manhasset, New York, Forente stater, 11030
- North Shore University Hospital
-
Middletown, New York, Forente stater, 10940
- Garnet Health Medical Center
-
New Hyde Park, New York, Forente stater, 11040
- Long Island Jewish Medical Center
-
New York, New York, Forente stater, 10065
- Memorial Sloan Kettering Cancer Center
-
Poughkeepsie, New York, Forente stater, 12601
- Vassar Brothers Medical Center
-
Syracuse, New York, Forente stater, 13210
- State University of New York Upstate Medical University
-
-
North Carolina
-
Asheville, North Carolina, Forente stater, 28801
- Mission Hospital
-
Burlington, North Carolina, Forente stater, 27215
- Cone Health Cancer Center at Alamance Regional
-
Chapel Hill, North Carolina, Forente stater, 27599
- UNC Lineberger Comprehensive Cancer Center
-
Concord, North Carolina, Forente stater, 28025
- Atrium Health Cabarrus/LCI-Concord
-
Durham, North Carolina, Forente stater, 27710
- Duke University Medical Center
-
Goldsboro, North Carolina, Forente stater, 27534
- Wayne Memorial Hospital
-
Greenville, North Carolina, Forente stater, 27834
- East Carolina University
-
Kinston, North Carolina, Forente stater, 28501
- ECU Health Oncology Kinston
-
Pinehurst, North Carolina, Forente stater, 28374
- FirstHealth of the Carolinas-Moore Regional Hospital
-
Raleigh, North Carolina, Forente stater, 27607
- UNC Rex Healthcare
-
Washington, North Carolina, Forente stater, 27889
- Marion L Shepard Cancer Center - ECU Health Beaufort Hospital
-
Winston-Salem, North Carolina, Forente stater, 27157
- Wake Forest University Health Sciences
-
-
North Dakota
-
Bismarck, North Dakota, Forente stater, 58501
- Sanford Bismarck Medical Center
-
Bismarck, North Dakota, Forente stater, 58501
- Mid Dakota Clinic
-
Bismarck, North Dakota, Forente stater, 58501
- Saint Alexius Medical Center
-
-
Ohio
-
Akron, Ohio, Forente stater, 44307
- Cleveland Clinic Akron General
-
Beachwood, Ohio, Forente stater, 44122
- Cleveland Clinic Cancer Center Beachwood
-
Canton, Ohio, Forente stater, 44710
- Aultman Health Foundation
-
Cleveland, Ohio, Forente stater, 44195
- Cleveland Clinic Foundation
-
Cleveland, Ohio, Forente stater, 44111
- Cleveland Clinic Cancer Center/Fairview Hospital
-
Columbus, Ohio, Forente stater, 43210
- Ohio State University Comprehensive Cancer Center
-
Dayton, Ohio, Forente stater, 45406
- Good Samaritan Hospital - Dayton
-
Dayton, Ohio, Forente stater, 45409
- Miami Valley Hospital
-
Dayton, Ohio, Forente stater, 45415
- Miami Valley Hospital North
-
Dayton, Ohio, Forente stater, 45405
- Grandview Hospital
-
Dayton, Ohio, Forente stater, 45459
- Dayton NCI Community Oncology Research Program
-
Findlay, Ohio, Forente stater, 45840
- Blanchard Valley Hospital
-
Franklin, Ohio, Forente stater, 45005-1066
- Atrium Medical Center-Middletown Regional Hospital
-
Greenville, Ohio, Forente stater, 45331
- Wayne Hospital
-
Independence, Ohio, Forente stater, 44131
- Cleveland Clinic Cancer Center Independence
-
Kettering, Ohio, Forente stater, 45429
- Kettering Medical Center
-
Lima, Ohio, Forente stater, 45801
- Saint Rita's Medical Center
-
Mayfield Heights, Ohio, Forente stater, 44124
- Hillcrest Hospital Cancer Center
-
Parma, Ohio, Forente stater, 44129
- University Hospitals Parma Medical Center
-
Strongsville, Ohio, Forente stater, 44136
- Cleveland Clinic Cancer Center Strongsville
-
Troy, Ohio, Forente stater, 45373
- Upper Valley Medical Center
-
Wilmington, Ohio, Forente stater, 45177
- Clinton Memorial Hospital/Foster J Boyd Regional Cancer Center
-
Wooster, Ohio, Forente stater, 44691
- Cleveland Clinic Wooster Family Health and Surgery Center
-
Xenia, Ohio, Forente stater, 45385
- Greene Memorial Hospital
-
-
Oklahoma
-
Oklahoma City, Oklahoma, Forente stater, 73104
- University of Oklahoma Health Sciences Center
-
Oklahoma City, Oklahoma, Forente stater, 73120
- Cancer Care Associates
-
-
Pennsylvania
-
Erie, Pennsylvania, Forente stater, 16505
- UPMC Hillman Cancer Center Erie
-
Hershey, Pennsylvania, Forente stater, 17033-0850
- Penn State Milton S Hershey Medical Center
-
Lewistown, Pennsylvania, Forente stater, 17044
- Lewistown Hospital
-
Sayre, Pennsylvania, Forente stater, 18840
- Guthrie Medical Group PC-Robert Packer Hospital
-
State College, Pennsylvania, Forente stater, 16803
- Mount Nittany Medical Center
-
-
Rhode Island
-
Warwick, Rhode Island, Forente stater, 02886
- Kent Hospital
-
-
South Carolina
-
Boiling Springs, South Carolina, Forente stater, 29316
- Prisma Health Cancer Institute - Spartanburg
-
Charleston, South Carolina, Forente stater, 29401
- Roper Hospital
-
Easley, South Carolina, Forente stater, 29640
- Prisma Health Cancer Institute - Easley
-
Greenville, South Carolina, Forente stater, 29605
- Prisma Health Cancer Institute - Faris
-
Greenville, South Carolina, Forente stater, 29615
- Prisma Health Cancer Institute - Eastside
-
Greenville, South Carolina, Forente stater, 29605
- Prisma Health Cancer Institute - Butternut
-
Greenville, South Carolina, Forente stater, 29601
- Saint Francis Hospital
-
Greenville, South Carolina, Forente stater, 29605
- Prisma Health Greenville Memorial Hospital
-
Greenville, South Carolina, Forente stater, 29601
- Greenville Health System Cancer Institute-Andrews
-
Greenwood, South Carolina, Forente stater, 29646
- Self Regional Healthcare
-
Greer, South Carolina, Forente stater, 29650
- Prisma Health Cancer Institute - Greer
-
Seneca, South Carolina, Forente stater, 29672
- Prisma Health Cancer Institute - Seneca
-
West Columbia, South Carolina, Forente stater, 29169
- Lexington Medical Center
-
-
Tennessee
-
Chattanooga, Tennessee, Forente stater, 37403
- Erlanger Medical Center
-
Nashville, Tennessee, Forente stater, 37208
- Meharry Medical College
-
Nashville, Tennessee, Forente stater, 37203
- Nashville Oncology Associates PC
-
-
Texas
-
Laredo, Texas, Forente stater, 78041
- Doctor's Hospital of Laredo
-
Lubbock, Texas, Forente stater, 79430
- Texas Tech University Health Sciences Center-Lubbock
-
-
Vermont
-
Berlin Corners, Vermont, Forente stater, 05602
- Central Vermont Medical Center/National Life Cancer Treatment
-
Burlington, Vermont, Forente stater, 05405
- University of Vermont and State Agricultural College
-
-
Virginia
-
Danville, Virginia, Forente stater, 24541
- Danville Regional Medical Center
-
Fredericksburg, Virginia, Forente stater, 22408
- Hematology Oncology Associates of Fredericksburg Inc
-
Lynchburg, Virginia, Forente stater, 24501
- Centra Alan B Pearson Regional Cancer Center
-
-
Washington
-
Anacortes, Washington, Forente stater, 98221
- Cancer Care Center at Island Hospital
-
Auburn, Washington, Forente stater, 98001
- MultiCare Auburn Medical Center
-
Bellingham, Washington, Forente stater, 98225
- PeaceHealth Saint Joseph Medical Center
-
Burien, Washington, Forente stater, 98166
- Highline Medical Center-Main Campus
-
Centralia, Washington, Forente stater, 98531
- Providence Regional Cancer System-Centralia
-
Federal Way, Washington, Forente stater, 98003
- Saint Francis Hospital
-
Kennewick, Washington, Forente stater, 99336
- Kadlec Clinic Hematology and Oncology
-
Kirkland, Washington, Forente stater, 98033
- EvergreenHealth Medical Center
-
Lakewood, Washington, Forente stater, 98499
- Saint Clare Hospital
-
Mount Vernon, Washington, Forente stater, 98274
- Skagit Valley Hospital
-
Olympia, Washington, Forente stater, 98506-5166
- Providence - Saint Peter Hospital
-
Poulsbo, Washington, Forente stater, 98370
- Harrison HealthPartners Hematology and Oncology-Poulsbo
-
Puyallup, Washington, Forente stater, 98372
- MultiCare Good Samaritan Hospital
-
Seattle, Washington, Forente stater, 98101
- Virginia Mason Medical Center
-
Seattle, Washington, Forente stater, 98122
- Swedish Medical Center-First Hill
-
Seattle, Washington, Forente stater, 98195
- University of Washington Medical Center - Montlake
-
Seattle, Washington, Forente stater, 98112
- Kaiser Permanente Washington
-
Seattle, Washington, Forente stater, 98104
- Minor and James Medical PLLC
-
Seattle, Washington, Forente stater, 98104
- Pacific Medical Center-First Hill
-
Sedro-Woolley, Washington, Forente stater, 98284
- PeaceHealth United General Medical Center
-
Silverdale, Washington, Forente stater, 98383
- Saint Michael Cancer Center
-
Spokane, Washington, Forente stater, 99204
- Providence Sacred Heart Medical Center and Children's Hospital
-
Spokane, Washington, Forente stater, 99218
- Evergreen Hematology and Oncology PS
-
Spokane, Washington, Forente stater, 99202
- Cancer Care Northwest - Spokane South
-
Spokane, Washington, Forente stater, 99208
- Providence Holy Family Hospital
-
Tacoma, Washington, Forente stater, 98405
- MultiCare Tacoma General Hospital
-
Tacoma, Washington, Forente stater, 98405
- MultiCare Allenmore Hospital
-
Tacoma, Washington, Forente stater, 98405
- Northwest NCI Community Oncology Research Program
-
Tacoma, Washington, Forente stater, 98405
- Saint Joseph Medical Center
-
Wenatchee, Washington, Forente stater, 98801
- Wenatchee Valley Hospital and Clinics
-
-
West Virginia
-
Huntington, West Virginia, Forente stater, 25702
- Saint Mary's Medical Center
-
Parkersburg, West Virginia, Forente stater, 26101
- Camden Clark Medical Center
-
-
Wisconsin
-
La Crosse, Wisconsin, Forente stater, 54601
- Gundersen Lutheran Medical Center
-
Milwaukee, Wisconsin, Forente stater, 53210
- Ascension Southeast Wisconsin Hospital - Saint Joseph Campus
-
-
Wyoming
-
Sheridan, Wyoming, Forente stater, 82801
- Welch Cancer Center
-
-
-
-
-
San Juan, Puerto Rico, 00936
- San Juan City Hospital
-
-
Deltakelseskriterier
Kvalifikasjonskriterier
Alder som er kvalifisert for studier
Tar imot friske frivillige
Beskrivelse
Inklusjonskriterier:
- Patologisk bekreftelse av invasiv brystkreft; pasienter med inflammatorisk brystkreft er ikke kvalifisert
Klinisk stadium II-III operabel invasiv brystkreft med hensikt å utføre kirurgisk reseksjon etter neoadjuvant terapi
- Pasienter med multisentrisk eller bilateral sykdom er kvalifisert så lenge mållesjonen oppfyller kvalifikasjonskriteriene for denne studien
- Stadieinndeling for å utelukke metastatisk sykdom anbefales for pasienter i klinisk stadium III
- Tumorer må være HER2 positive definert som HER2 3+ ved immunhistokjemiske (IHC) analyser eller genamplifikasjon ved fluorescens in situ hybridisering (FISH) med et forhold på >= 2 på invasiv tumor
- Status for østrogenreseptor (ER) og progesteronreseptor (PgR) må være kjent
- Mållesjonen i brystet må være >= 1 cm ved fysisk undersøkelse eller ved radiografisk måling; palpabel aksillær adenopati vil bli dokumentert, men ikke tjene som målbar sykdom for det primære endepunktet; Pasienter med kun aksillær sykdom er ikke kvalifisert til å delta
- Pasienten godtar å gi forbehandlingsbiopsier
- Ingen tidligere kjemoterapi, hormonbehandling, biologisk eller strålebehandling med terapeutisk hensikt for denne kreften
- Hjerteejeksjonsfraksjonen må være >= 50 % ved ekkokardiogram eller MUGA-skanning (multiple gated acquisition)
- Eastern Cooperative Oncology Group (ECOG) (Zubrod) ytelsesstatus 0-1
- Pasienter må ikke være gravide eller ammende
- Absolutt nøytrofiltall (ANC) >= 1000/ul
- Blodplateantall >= 100 000/ul
- Bilirubin =< 1,5 ganger øvre normalgrense
- Aspartataminotransferase (AST) og alaninaminotransferase (ALT) =< 2,5 ganger øvre normalgrense (ULN)
- Serum beta-humant koriongonadotropin (HCG) negativt (hos kvinnelige pasienter med mindre status etter (s/p) hysterektomi eller menopausal eller ingen menstruasjon i 24 påfølgende måneder); analysen må ha en sensitivitet på minst 50 mIU/ml
Studieplan
Hvordan er studiet utformet?
Designdetaljer
- Primært formål: Behandling
- Tildeling: Randomisert
- Intervensjonsmodell: Parallell tildeling
- Masking: Ingen (Open Label)
Våpen og intervensjoner
Deltakergruppe / Arm |
Intervensjon / Behandling |
|---|---|
|
Eksperimentell: Arm I (THL)
Pasienter får trastuzumab 2 mg/kg IV over 30-90 minutter og paklitaksel 80 mg/m^2 IV over 1 time én gang ukentlig og lapatinibditosylat 750 mg PO én gang daglig i 16 uker i fravær av sykdomsprogresjon eller uakseptabel toksisitet.
|
Korrelative studier
Gitt IV
Andre navn:
Gitt IV
Andre navn:
Gitt PO
Andre navn:
|
|
Aktiv komparator: Arm II (TH)
Pasienter får trastuzumab 2 mg/kg IV over 30-90 minutter og paklitaksel 80 mg/m^2 IV over 1 time én gang ukentlig i 16 uker i fravær av sykdomsprogresjon eller uakseptabel toksisitet.
|
Korrelative studier
Gitt IV
Andre navn:
Gitt IV
Andre navn:
|
|
Eksperimentell: Arm III (TL)
Pasienter får paklitaksel 80 mg/m^2 IV over 1 time én gang ukentlig og lapatinibditosylat 15000 mg PO én gang daglig i 16 uker i fravær av sykdomsprogresjon eller uakseptabel toksisitet.
(Utgått fra 6-15-11)
|
Gitt IV
Andre navn:
Gitt PO
Andre navn:
|
Hva måler studien?
Primære resultatmål
Resultatmål |
Tiltaksbeskrivelse |
Tidsramme |
|---|---|---|
|
pCR-hastighet
Tidsramme: Ved operasjonstidspunktet
|
Fullstendig patologisk respons er definert som fravær av gjenværende invasivt karsinom i brystet på tidspunktet for definitiv kirurgisk fjerning.
Patologisk fullstendig respons i lymfeknutene er definert som ingen påvisbar invasiv svulst av H&E.
Analyse vil bruke en kjikvadrattest for forskjellen i proporsjoner av pasienter på THL-armen versus TH-armen som oppnår en pCR.
Nøyaktige binomiale metoder vil bli brukt for å konstruere 95 % konfidensintervaller rundt pCR-forekomsten for hver arm.
|
Ved operasjonstidspunktet
|
Sekundære resultatmål
Resultatmål |
Tiltaksbeskrivelse |
Tidsramme |
|---|---|---|
|
Radiografisk responsrate (ved fullføring av neoadjuvant terapi)
Tidsramme: Uke 16
|
Responsen ble definert av responsevalueringskriteriene i solide svulster (RECIST).
En responderende deltaker hadde enten en fullstendig respons (forsvinning av alle mållesjoner) eller delvis respons (30 % reduksjon i summen av mållesjonens lengste diameter).
|
Uke 16
|
|
Forekomst av uønskede hendelser som gradert av National Cancer Institute Common Terminology Criteria for Adverse Events Versjon 3
Tidsramme: Inntil 30 dager etter behandling
|
Type og grad av behandlingsrelatert toksisitet vil bli tabellert etter behandlingsarm.
|
Inntil 30 dager etter behandling
|
|
Pathologic Stage in the Breast and Axilla
Tidsramme: At time of surgery
|
Stage will be determined by the American Joint Committee on Cancer (AJCC) TNM (tumor, lymph nodes, metastasis) staging system.
yT0: No evidence of residual invasive primary tumor.
yTis: Carcinoma in situ only (presence of ductal carcinoma in situ [DCIS] but completely free of invasive cancer).
yT1: Residual invasive tumor <= 2 in greatest dimension.yT2:
Residual invasive tumor > 2 cm but <= 5 cm in greatest dimension.yT3:
Residual invasive tumor > 5 cm in greatest dimension.yT4:
Residual tumor of any size with direct extension to the chest wall and/or skin (including ulceration or macroscopic nodules).
|
At time of surgery
|
|
Overall Survival Rate
Tidsramme: Time from randomization to death or last follow-up (up to 10 years)
|
Overall survival was measured as the interval from study entry until death, from any cause, or last contact.
Distribution was estimated using the Kaplan Meier product-limit method
|
Time from randomization to death or last follow-up (up to 10 years)
|
|
Relapse-free Survival (RFS) Rate
Tidsramme: Time from surgery to any recurrence (up to 10 years)
|
Relapse free survival is defined as the interval from definitive surgery to ipsilateral invasive breast tumor recurrence, regional invasive breast cancer recurrence, distant recurrence, or death from any cause, whichever occurs first.
Patients who have not experienced any of these events will be censored at the date of last clinical assessment.
Patients who do not undergo definitive surgery will not be assessable for RFS.
Distribution was estimated using the Kaplan Meier product-limit method.
Relapse-free survival (RFS) Rate is the rate of patients alive and relapse free.
|
Time from surgery to any recurrence (up to 10 years)
|
|
Time to First Failure
Tidsramme: Time from surgery to any recurrence (up to 10 years)
|
Time to first failure is defined as the interval from study entry to ipsilateral invasive breast tumor recurrence, regional invasive breast cancer recurrence, distant recurrence or death from any cause.
Patients who have not experienced any of these events will be censored at the date of last clinical assessment.
Distribution was estimated using the Kaplan Meier product-limit method.
|
Time from surgery to any recurrence (up to 10 years)
|
Samarbeidspartnere og etterforskere
Sponsor
Etterforskere
- Hovedetterforsker: Lisa A Carey, Alliance for Clinical Trials in Oncology
Publikasjoner og nyttige lenker
Generelle publikasjoner
- Fernandez-Martinez A, Krop IE, Hillman DW, Polley MY, Parker JS, Huebner L, Hoadley KA, Shepherd J, Tolaney S, Henry NL, Dang C, Harris L, Berry D, Hahn O, Hudis C, Winer E, Partridge A, Perou CM, Carey LA. Survival, Pathologic Response, and Genomics in CALGB 40601 (Alliance), a Neoadjuvant Phase III Trial of Paclitaxel-Trastuzumab With or Without Lapatinib in HER2-Positive Breast Cancer. J Clin Oncol. 2020 Dec 10;38(35):4184-4193. doi: 10.1200/JCO.20.01276. Epub 2020 Oct 23.
- Carey LA, Berry DA, Cirrincione CT, Barry WT, Pitcher BN, Harris LN, Ollila DW, Krop IE, Henry NL, Weckstein DJ, Anders CK, Singh B, Hoadley KA, Iglesia M, Cheang MC, Perou CM, Winer EP, Hudis CA. Molecular Heterogeneity and Response to Neoadjuvant Human Epidermal Growth Factor Receptor 2 Targeting in CALGB 40601, a Randomized Phase III Trial of Paclitaxel Plus Trastuzumab With or Without Lapatinib. J Clin Oncol. 2016 Feb 20;34(6):542-9. doi: 10.1200/JCO.2015.62.1268. Epub 2015 Nov 2.
- Jaehnig EJ, Fernandez-Martinez A, Vashist TD, Holt MV, Williams L, Lei JT, Moon CI, Kim BJ, Dou Y, Zhao H, Korchina V, Gibbs RA, Muzny DM, Doddapaneni H, Perou CM, Carey LA, Robles AI, Hyslop T, Wen Y, McCart L, Krek A, Petralia F, Miles G, Kavuri SM, Gillette MA, Mani DR, Carr SA, Zhang B, Ellis MJ, Satpathy S, Anurag M. Proteogenomic analysis of the CALGB 40601 (Alliance) HER2+ breast cancer neoadjuvant trial reveals resistance biomarkers. Cell Rep Med. 2025 Jun 17;6(6):102154. doi: 10.1016/j.xcrm.2025.102154. Epub 2025 Jun 5.
Studierekorddatoer
Studer hoveddatoer
Studiestart (Faktiske)
Primær fullføring (Faktiske)
Studiet fullført (Faktiske)
Datoer for studieregistrering
Først innsendt
Først innsendt som oppfylte QC-kriteriene
Først lagt ut (Antatt)
Oppdateringer av studieposter
Sist oppdatering lagt ut (Faktiske)
Siste oppdatering sendt inn som oppfylte QC-kriteriene
Sist bekreftet
Mer informasjon
Begreper knyttet til denne studien
Ytterligere relevante MeSH-vilkår
- Neoplasmer etter nettsted
- Neoplasmer
- Hudsykdommer
- Bryst sykdommer
- Hud- og bindevevssykdommer
- Brystneoplasmer
- Brystneoplasmer, mannlige
- Aminosyrer, peptider og proteiner
- Proteiner
- Organiske kjemikalier
- Heterocykliske forbindelser
- Heterocykliske forbindelser, 2-ring
- Heterocykliske forbindelser, smeltet ringen
- Hydrokarboner
- Cycloparaffins
- Hydrokarboner, alicyklisk
- Hydrokarboner, syklisk
- Terpener
- Antistoffer, monoklonalt, humanisert
- Antistoffer, monoklonalt
- Antistoffer
- Immunoglobuliner
- Immunoproteiner
- Blodproteiner
- Serumglobuliner
- Globuliner
- Taxoider
- Cyclodecanes
- Diterpenes
- Helsevesenets økonomi og organisasjoner
- Quinazolines
- Økonomi
- Trastuzumab
- Lapatinib
- Paclitaxel
- CT-P6
- PF-05280014
- trastuzumab biosimilar hlx02
- Ogivri
- Ontruzant
- Skatter
Andre studie-ID-numre
- NCI-2009-01073 (Registeridentifikator: CTRP (Clinical Trial Reporting Program))
- U10CA180821 (U.S. NIH-stipend/kontrakt)
- U10CA031946 (U.S. NIH-stipend/kontrakt)
- CDR0000616648
- CALGB 40601 (Annen identifikator: Alliance for Clinical Trials in Oncology)
- CALGB-40601 (Annen identifikator: CTEP)
Denne informasjonen ble hentet direkte fra nettstedet clinicaltrials.gov uten noen endringer. Hvis du har noen forespørsler om å endre, fjerne eller oppdatere studiedetaljene dine, vennligst kontakt register@clinicaltrials.gov. Så snart en endring er implementert på clinicaltrials.gov, vil denne også bli oppdatert automatisk på nettstedet vårt. .